A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Investigational Treatment Gaining Traction Online
Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to message these profiles privately for source information, while also receiving discount codes.
Active Commerce on Social Networks
Additionally, a robust market exists on messaging services, where communities with thousands of members share “before and after” images, administration instructions and claims of rapid UK delivery. Vendors promote the drug there before directing buyers to other platforms for transactions.
Learning About The Experimental Drug
This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Professionals Express Concerns
However, doctors and pharmacists have cautions that the sale of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals administering products of unknown origin.
Several professionals stated the popularity for the experimental drug could be connected to the increasing cost of licensed weight loss products such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Several content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and customer regulations, risking penalties, legal action or prison.
Platform Response and Content Removal
Based on the social media company, the service has removed violative material and banned related hashtags and query recommendations. The organization stated it was committed to maintaining the platform safe and allocating resources in strengthening compliance measures.
Digital Trading Operations
Investigations also discovered communities with up to 9,000 participants marketing the experimental drug using the platform's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays channels with numerous of members, filled with images of slimming results, glowing testimonials and detailed guides for mixing or injecting at home.
Within minutes of joining one group, a vendor shared WhatsApp details, where the majority of transactions take place. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about body mass, medical conditions or past usage.
Product Information and Pricing
Within these groups, posts show dark colored packages with postal service labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at residence with purified liquid, or ready-to-use pens typically priced at £160 for 20 milligrams. When questioned how much time a pen should last, vendors give contradictory answers ranging from a several days to “depends on your body”.
Service Moderation and Security Actions
A spokesperson for Telegram stated it actively moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are injecting materials they can’t verify. Even if the research behind this drug is valid, these digital versions may not include what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her staff has already encountered individuals injured by personal administration from unverified sources. “We understand the frustration, but buying from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental product not yet approved … may subject patients to potentially significant medical dangers”.
